MétaCan
Menu
Back to cohort
Record W4415147311 · doi:10.1002/jeo2.70442

A randomised controlled trial confirms the non‐superiority of bone marrow aspirate (BMA) from the posterior iliac crest and proximal tibia compared to platelet rich plasma (PRP) in the treatment of knee osteoarthritis

2025· article· en· W4415147311 on OpenAlexaboutno aff
Elisabetta Mormone, Marco Sandri, Francesco Maruccia, Giovanni Rossi, Nicola Pio Sinisi, Franco Lucio Gorgoglione

Bibliographic record

VenueJournal of Experimental Orthopaedics · 2025
Typearticle
Languageen
FieldMedicine
TopicPeriodontal Regeneration and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsIliac crestBone marrow aspirateOsteoarthritisPlatelet-rich plasmaRandomized controlled trialOrthopedic surgeryTibia

Abstract

fetched live from OpenAlex

Abstract Purpose The reported clinical trial aimed to determine the clinical efficacy of ex vivo mesenchymal stromal cells (MSCs) derived from bone marrow (BM), aspirated from the posterior iliac crest and proximal tibia, in comparison to autologous platelet‐rich plasma (PRP) for the knee osteoarthritis (KOA) treatment and to assess the differences in cellular yield between the two harvest sites. Methods A single‐centre, parallel, randomised controlled trial was designed to investigate the clinical effects of bone marrow aspirate (BMA) from the posterior iliac crest compared to BMA from the proximal tibia in treating KOA, with a control group receiving PRP. Ninety patients with KOA were divided equally among the three groups. Visual Analogue Score (VAS) and Western Ontario and McMaster Universities Arthritis Index (WOMAC) score were used for clinical outcome evaluation at 6 months after the treatment, and cellular analysis of BMA was performed. Results Cell count confirmed that the posterior iliac crest was significantly more densely populated with mononuclear cells than the proximal tibia. Flow cytometric analysis of ex vivo BMA also confirmed a significantly greater number of MSCs in the BM‐derived from the posterior iliac crest when compared with the proximal tibia, together with a significantly higher number of platelets. The analysis confirmed that the improvement in early pain and function scores after each treatment was statistically significant within each of the three groups (median VAS decrease: PRP Group −2 ( p < 0.001), Crest Group −2 ( p < 0.001), Tibia Group −2 ( p < 0.001)), (median WOMAC decrease: PRP Group −13.5 ( p < 0.001), Crest Group −12.5 ( p < 0.001), Tibia Group −12 ( p < 0.001)). However, no statistically significant differences were observed in the improvements among the three study groups. A significantly greater improvement in VAS was observed in patients with Kellgren Lawrence (KL) I–II. In the Tibia Group, the effect of BMA on the change in VAS was associated with BMI and %MSCs, whereas in the Crest Group, the change in WOMAC score was associated with %BM and platelet count. Conclusion The iliac crest yields a higher concentration of MSCs compared to the proximal tibia. However, both sources demonstrated a beneficial clinical outcome in the treatment of KOA, with no evidence of superiority over PRP treatment. Level of Evidence Level I.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.008
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.009
Threshold uncertainty score0.044

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0080.008
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0060.003
Bibliometrics0.0010.001
Science and technology studies0.0010.003
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0090.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.292
Teacher spread0.274 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Experimental OrthopaedicsSame topicPeriodontal Regeneration and TreatmentsFrench-language works237,207